Don't missed it: “Biomarkers of NRF2 Activation “in Non-Communicable Diseases”
🗓 28 october 2025
🕒 15:00 - 17:00 (CET)
The detailed programme: www.antiox.it/home-redox
Great energy at the COST Action BenBedPhar meeting in Istanbul! Researchers from across Europe discussed the latest on NRF2 and its translational potential in chronic diseases. Collaboration, science & progress at their best! 💡
#BenBedPhar #NRF2 #Science
A fantastic finale at Kadir Has Istanbul for the #BenBedPhar MC&Scientific Meeting. Delivered WG3 report, presented our new research, and chaired #NRF2 scientific session. Grateful for an incredible 4 years with this brilliant #COST Action community—a truly unique journey 🎉
@benbedphar.bsky.social
📚 Our new review is out! @benbedphar.bsky.social WG3 dives deep into measuring #NRF2 activity across diseases and how to translate these biomarkers into clinical practice for better patient care.
Massive thanks to the fantastic team behind this work! 🙌
#NCD #COST #stress
🔗 doi.org/10.1016/j.re...
Don't missed it: “Biomarkers of NRF2 Activation “in Non-Communicable Diseases”
🗓 28 october 2025
🕒 15:00 - 17:00 (CET)
The detailed programme: www.antiox.it/home-redox
11th BenBedPhar Scientific meeting
Targeting NRF2: Translating Redox Biology Across Disorders
October 9 - 10, 2025
Location: Istanbul, Turkey
Participants: members of the Management Committee and Work Groups of the COST Action CA20121
benbedphar.org/11th-benbedp...
We are pleased to announce the next BenBedPhar Webinar:
“NRF2 and Aging: Proteostasis and Redox Imbalance”
🗓 Tuesday, 30 September 2025
🕒 3:00 PM – 5:00 PM (CEST)
This webinar will explore the role of NRF2 in the aging process and age-related diseases. Registration: www.antiox.it/home-redox/
We are pleased to announce the next BenBedPhar Webinar:
“NRF2 and Aging: Proteostasis and Redox Imbalance”
🗓 Tuesday, 30 September 2025
🕒 3:00 PM – 5:00 PM (CEST)
This webinar will explore the role of NRF2 in the aging process and age-related diseases. Registration: www.antiox.it/home-redox/
Kicking off the 9th @benbedphar.bsky.social Scientific Meeting at Sapienza University in Rome with an insightful session on cellular stress responses and monitoring #NRF2 activity through biomarkers by @iancopple.bsky.social - what a great start!🤩
#MedSky
#ImmunoSky
Shared progress on @benbedphar.bsky.social BenBedPhar Working Group 3's deliverables at the scientific meeting in Rome 🗣️. Grateful to everyone contributing and advancing translational #NRF2 research in #NCDs 🙌. And a big thanks to the organizers at Sapienza University! 👏
#MedSky #COST
Coming to the end of a fantastic few days in Rome participating in the @benbedphar.bsky.social meeting at Sapienza University. Great discussions about progress and next steps for NRF2 pharmacology. Managed to squeeze in a Parkrun too! 🏃🏻♂️
Another month,another meeting-this time at the Institute of Evolutionary Medicine in Zürich where we dove into #NRF2's role in #NCDs, and I had the chance to showcase how #bioinformatics and #AI can revolutionize NRF2 research! Big thanks to the organizers for a great event
@benbedphar.bsky.social
Earlier this month I had a fantastic time in Galway, Ireland attending the SFRRI biennial meeting and the @benbedphar.bsky.social satellite meeting. Nice to catch up with friends and colleagues, including the 'Godfather' of the NRF2 field Masi Yamamoto!
Excited to be on my Short-term Scientific Mission at @uniuef.bsky.social in beautiful Kuopio 🇫🇮! Huge thanks to Prof. Katja Kanninen and her team for hosting. Gaining valuable experience for #CRS #biomarker research 🧪
Grateful to #COST action @benbedphar.bsky.social for this opportunity! 🌍
🚨 Join us today and tomorrow at the I MITONED INTERNATIONAL WORKSHOP
Dive into groundbreaking discussions on mitochondrial research, from treatments for mitochondrial disorders to neurodegeneration insights.
📍@ibis_sevilla , Salón de Actos
🕒 Starts at 14:45
My NIH study section that was to meet tomorrow was one of those canceled. This represents many months of work by the applicants and by the NIH staff and reviewers. Devastating is the correct word.
🚨 OFERTA CONTRATO TECNICO DE LABORATORIO👩🏻🔬:
Si quieres trabajar en Párkinson, únete a nuestro equipo!
Plazo de solicitudes: 24 al 30 de enero‼️
Convocatoria: investigacion.us.es/sisiusapp/op...
Cualquier duda o pregunta, escríbeme por DM o al email: pgonzalez4@us.es
Machine Learning in Drug Discovery Resources page updated for 2025. github.com/PatWalters/r...
📢 Last chance to submit your project to #OpenChagas!
If you're in #LatinAmerica and working on:
👉 New chemical entities
👉 Repurposed drugs
👉 Natural products
👉 Innovative combinations targeting #ChagasDisease
🗓️ Deadline: Jan 31, 2025 – next week!
🔗 dndi.org/open-chagas/
We have a vacancy in assay development, compound profiling, and screening to help progress the cancer drug discovery projects of the Centre for Cancer Drug Discovery @icrlondon.bsky.social. If you are interested please check out the details below.
jobs.icr.ac.uk/vacancies/11...
Are you interested in the inflammatory process, #NRF2, and #Alzheimer'sDisease? Then you can't miss this publication by our COST Action members!
Take a look at the publication by one of our COST Action members in the special issue "Role of the NRF2 Pathway in Neurodegenerative Diseases." Don't miss it!
Now accepting submission. For more information please contact the Assistant Editor Dixon Liu (dixon.liu@mdpi.com)
@benbedphar.bsky.social
members are welcome to submit
As 2024 draws to a close, we would like to extend our heartfelt thanks to all members, and collaborators, for making this year a truly impactful one. As we step into 2025, we look forward to continuing this journey together. May this festive season bring you joy, peace, and cherished moments!
This insightful review by @benbedphar.bsky.social brilliantly synthesizes an in-depth overview of model organisms used to study #NRF2 modulation in non-communicable diseases, highlighting their potential in drug development and future research challenges. #NCD
www.sciencedirect.com/science/arti...
